Focal refractory epilepsy associated to 15q13.3 microduplication

Area of Science:

• Genetics
• Neurology
• Epilepsy Research

Background:

• Presents a case of drug-resistant epilepsy (DRE) in a young male with a family history of epilepsy and psychiatric disorders.
• Epilepsy onset at age 5, following mild head trauma, with progression to frequent generalized and focal seizures.
• Failure to achieve seizure control with standard antiepileptic drugs including carbamazepine, levetiracetam, and gabapentin.

Purpose of the Study:

• To investigate the genetic basis of drug-resistant epilepsy in a young adult.
• To explore the association between 15q13.3 microduplication and severe epilepsy phenotypes.
• To highlight the clinical implications and management challenges posed by 15q13.3 copy number variations.

Main Methods:

• Clinical presentation and diagnostic evaluation of a patient with refractory epilepsy.
• Genetic testing to identify chromosomal abnormalities, specifically microduplications.
• Brain Magnetic Resonance Imaging (MRI) for structural abnormalities.

Main Results:

• Identification of a 440.5 Kb microduplication at 15q13.3, encompassing the CHRNA7 gene.
• Brain MRI revealed non-specific gliosis in the left frontal subcortical region.
• The genetic finding correlates with known associations of 15q13.3 copy number variations with epilepsy and neurodevelopmental disorders.

Conclusions:

• 15q13.3 microduplications are associated with complex epilepsy phenotypes and variable penetrance, complicating patient management.
• Current treatment strategies for epilepsy linked to 15q13.3 microduplications are undefined.
• Emphasizes the need for genetic evaluation and personalized treatment approaches in DRE, with further research crucial for therapeutic advancements.